nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropinirole—CYP2D6—Niacin—atherosclerosis	0.0591	0.169	CbGbCtD
Ropinirole—CYP2D6—Simvastatin—atherosclerosis	0.0467	0.134	CbGbCtD
Ropinirole—CYP2D6—Lovastatin—atherosclerosis	0.0457	0.131	CbGbCtD
Ropinirole—CYP2D6—Pravastatin—atherosclerosis	0.0457	0.131	CbGbCtD
Ropinirole—CYP3A4—Rosuvastatin—atherosclerosis	0.032	0.0916	CbGbCtD
Ropinirole—CYP3A4—Ezetimibe—atherosclerosis	0.032	0.0916	CbGbCtD
Ropinirole—CYP3A4—Simvastatin—atherosclerosis	0.0297	0.0851	CbGbCtD
Ropinirole—CYP3A4—Lovastatin—atherosclerosis	0.0291	0.0833	CbGbCtD
Ropinirole—CYP3A4—Pravastatin—atherosclerosis	0.0291	0.0833	CbGbCtD
Ropinirole—HTR2A—arteriole—atherosclerosis	0.00534	0.154	CbGeAlD
Ropinirole—HTR2A—vein—atherosclerosis	0.00318	0.0917	CbGeAlD
Ropinirole—HTR1B—artery—atherosclerosis	0.0027	0.0777	CbGeAlD
Ropinirole—HTR1D—artery—atherosclerosis	0.00261	0.0752	CbGeAlD
Ropinirole—HTR2A—hindlimb—atherosclerosis	0.00212	0.0609	CbGeAlD
Ropinirole—HTR1B—blood vessel—atherosclerosis	0.0021	0.0605	CbGeAlD
Ropinirole—HTR1D—blood vessel—atherosclerosis	0.00203	0.0586	CbGeAlD
Ropinirole—HTR2A—appendage—atherosclerosis	0.00181	0.0523	CbGeAlD
Ropinirole—HTR2A—artery—atherosclerosis	0.0013	0.0374	CbGeAlD
Ropinirole—HTR2A—endothelium—atherosclerosis	0.0011	0.0316	CbGeAlD
Ropinirole—HTR1D—connective tissue—atherosclerosis	0.00104	0.03	CbGeAlD
Ropinirole—HTR2A—blood vessel—atherosclerosis	0.00101	0.0291	CbGeAlD
Ropinirole—HTR1B—cardiovascular system—atherosclerosis	0.000937	0.027	CbGeAlD
Ropinirole—HTR1D—cardiovascular system—atherosclerosis	0.000907	0.0261	CbGeAlD
Ropinirole—HTR2B—cardiovascular system—atherosclerosis	0.000844	0.0243	CbGeAlD
Ropinirole—HTR1A—cardiovascular system—atherosclerosis	0.000756	0.0218	CbGeAlD
Ropinirole—HTR2B—adipose tissue—atherosclerosis	0.000744	0.0214	CbGeAlD
Ropinirole—ADRA2A—connective tissue—atherosclerosis	0.000609	0.0175	CbGeAlD
Ropinirole—ADRA2C—adipose tissue—atherosclerosis	0.000586	0.0169	CbGeAlD
Ropinirole—HTR2A—connective tissue—atherosclerosis	0.000518	0.0149	CbGeAlD
Ropinirole—ADRA2A—adipose tissue—atherosclerosis	0.000467	0.0135	CbGeAlD
Ropinirole—HTR2A—cardiovascular system—atherosclerosis	0.000451	0.013	CbGeAlD
Ropinirole—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000445	0.00115	CcSEcCtD
Ropinirole—Anaemia—Ezetimibe—atherosclerosis	0.000443	0.00115	CcSEcCtD
Ropinirole—Tinnitus—Pravastatin—atherosclerosis	0.000443	0.00115	CcSEcCtD
Ropinirole—Malaise—Lovastatin—atherosclerosis	0.000441	0.00114	CcSEcCtD
Ropinirole—Cardiac disorder—Pravastatin—atherosclerosis	0.000441	0.00114	CcSEcCtD
Ropinirole—Flushing—Pravastatin—atherosclerosis	0.000441	0.00114	CcSEcCtD
Ropinirole—Muscle spasms—Simvastatin—atherosclerosis	0.00044	0.00114	CcSEcCtD
Ropinirole—Vertigo—Lovastatin—atherosclerosis	0.000439	0.00114	CcSEcCtD
Ropinirole—Angioedema—Ezetimibe—atherosclerosis	0.000438	0.00113	CcSEcCtD
Ropinirole—Angiopathy—Niacin—atherosclerosis	0.000438	0.00113	CcSEcCtD
Ropinirole—Leukopenia—Lovastatin—atherosclerosis	0.000438	0.00113	CcSEcCtD
Ropinirole—Chills—Niacin—atherosclerosis	0.000433	0.00112	CcSEcCtD
Ropinirole—Malaise—Ezetimibe—atherosclerosis	0.000432	0.00112	CcSEcCtD
Ropinirole—Vision blurred—Simvastatin—atherosclerosis	0.000431	0.00112	CcSEcCtD
Ropinirole—Arrhythmia—Niacin—atherosclerosis	0.000431	0.00112	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000429	0.00111	CcSEcCtD
Ropinirole—Tremor—Simvastatin—atherosclerosis	0.000428	0.00111	CcSEcCtD
Ropinirole—Alopecia—Niacin—atherosclerosis	0.000426	0.0011	CcSEcCtD
Ropinirole—Chills—Pravastatin—atherosclerosis	0.000426	0.0011	CcSEcCtD
Ropinirole—Insomnia—Rosuvastatin—atherosclerosis	0.000426	0.0011	CcSEcCtD
Ropinirole—Ill-defined disorder—Simvastatin—atherosclerosis	0.000424	0.0011	CcSEcCtD
Ropinirole—Arrhythmia—Pravastatin—atherosclerosis	0.000424	0.0011	CcSEcCtD
Ropinirole—Palpitations—Ezetimibe—atherosclerosis	0.000424	0.0011	CcSEcCtD
Ropinirole—Paraesthesia—Rosuvastatin—atherosclerosis	0.000423	0.0011	CcSEcCtD
Ropinirole—Anaemia—Simvastatin—atherosclerosis	0.000423	0.00109	CcSEcCtD
Ropinirole—Malnutrition—Niacin—atherosclerosis	0.00042	0.00109	CcSEcCtD
Ropinirole—Alopecia—Pravastatin—atherosclerosis	0.00042	0.00109	CcSEcCtD
Ropinirole—Cough—Ezetimibe—atherosclerosis	0.000418	0.00108	CcSEcCtD
Ropinirole—Angioedema—Simvastatin—atherosclerosis	0.000418	0.00108	CcSEcCtD
Ropinirole—Arthralgia—Lovastatin—atherosclerosis	0.000416	0.00108	CcSEcCtD
Ropinirole—Chest pain—Lovastatin—atherosclerosis	0.000416	0.00108	CcSEcCtD
Ropinirole—Myalgia—Lovastatin—atherosclerosis	0.000416	0.00108	CcSEcCtD
Ropinirole—Anxiety—Lovastatin—atherosclerosis	0.000415	0.00107	CcSEcCtD
Ropinirole—Dyspepsia—Rosuvastatin—atherosclerosis	0.000414	0.00107	CcSEcCtD
Ropinirole—Hypertension—Ezetimibe—atherosclerosis	0.000414	0.00107	CcSEcCtD
Ropinirole—Flatulence—Niacin—atherosclerosis	0.000414	0.00107	CcSEcCtD
Ropinirole—Malaise—Simvastatin—atherosclerosis	0.000412	0.00107	CcSEcCtD
Ropinirole—Tension—Niacin—atherosclerosis	0.000412	0.00107	CcSEcCtD
Ropinirole—Discomfort—Lovastatin—atherosclerosis	0.000411	0.00107	CcSEcCtD
Ropinirole—Vertigo—Simvastatin—atherosclerosis	0.000411	0.00106	CcSEcCtD
Ropinirole—ADRA2C—liver—atherosclerosis	0.000411	0.0118	CbGeAlD
Ropinirole—Leukopenia—Simvastatin—atherosclerosis	0.000409	0.00106	CcSEcCtD
Ropinirole—Myalgia—Ezetimibe—atherosclerosis	0.000408	0.00106	CcSEcCtD
Ropinirole—Chest pain—Ezetimibe—atherosclerosis	0.000408	0.00106	CcSEcCtD
Ropinirole—Arthralgia—Ezetimibe—atherosclerosis	0.000408	0.00106	CcSEcCtD
Ropinirole—Nervousness—Niacin—atherosclerosis	0.000408	0.00106	CcSEcCtD
Ropinirole—Flatulence—Pravastatin—atherosclerosis	0.000407	0.00106	CcSEcCtD
Ropinirole—Dry mouth—Lovastatin—atherosclerosis	0.000407	0.00105	CcSEcCtD
Ropinirole—Tension—Pravastatin—atherosclerosis	0.000406	0.00105	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000405	0.00105	CcSEcCtD
Ropinirole—Dysgeusia—Pravastatin—atherosclerosis	0.000405	0.00105	CcSEcCtD
Ropinirole—Muscle spasms—Niacin—atherosclerosis	0.000404	0.00105	CcSEcCtD
Ropinirole—Discomfort—Ezetimibe—atherosclerosis	0.000403	0.00104	CcSEcCtD
Ropinirole—Pain—Rosuvastatin—atherosclerosis	0.000403	0.00104	CcSEcCtD
Ropinirole—Constipation—Rosuvastatin—atherosclerosis	0.000403	0.00104	CcSEcCtD
Ropinirole—Confusional state—Lovastatin—atherosclerosis	0.000402	0.00104	CcSEcCtD
Ropinirole—Nervousness—Pravastatin—atherosclerosis	0.000402	0.00104	CcSEcCtD
Ropinirole—Dry mouth—Ezetimibe—atherosclerosis	0.000399	0.00103	CcSEcCtD
Ropinirole—Muscle spasms—Pravastatin—atherosclerosis	0.000398	0.00103	CcSEcCtD
Ropinirole—Infection—Lovastatin—atherosclerosis	0.000396	0.00103	CcSEcCtD
Ropinirole—Vision blurred—Niacin—atherosclerosis	0.000396	0.00103	CcSEcCtD
Ropinirole—Confusional state—Ezetimibe—atherosclerosis	0.000395	0.00102	CcSEcCtD
Ropinirole—Thrombocytopenia—Lovastatin—atherosclerosis	0.000391	0.00101	CcSEcCtD
Ropinirole—Vision blurred—Pravastatin—atherosclerosis	0.00039	0.00101	CcSEcCtD
Ropinirole—Arthralgia—Simvastatin—atherosclerosis	0.000389	0.00101	CcSEcCtD
Ropinirole—Chest pain—Simvastatin—atherosclerosis	0.000389	0.00101	CcSEcCtD
Ropinirole—Myalgia—Simvastatin—atherosclerosis	0.000389	0.00101	CcSEcCtD
Ropinirole—Infection—Ezetimibe—atherosclerosis	0.000389	0.00101	CcSEcCtD
Ropinirole—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000388	0.001	CcSEcCtD
Ropinirole—Anxiety—Simvastatin—atherosclerosis	0.000388	0.001	CcSEcCtD
Ropinirole—Tremor—Pravastatin—atherosclerosis	0.000387	0.001	CcSEcCtD
Ropinirole—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000385	0.000997	CcSEcCtD
Ropinirole—Discomfort—Simvastatin—atherosclerosis	0.000385	0.000996	CcSEcCtD
Ropinirole—Nervous system disorder—Ezetimibe—atherosclerosis	0.000384	0.000994	CcSEcCtD
Ropinirole—Angioedema—Niacin—atherosclerosis	0.000384	0.000994	CcSEcCtD
Ropinirole—Ill-defined disorder—Pravastatin—atherosclerosis	0.000384	0.000994	CcSEcCtD
Ropinirole—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000383	0.000993	CcSEcCtD
Ropinirole—Anaemia—Pravastatin—atherosclerosis	0.000382	0.00099	CcSEcCtD
Ropinirole—Anorexia—Lovastatin—atherosclerosis	0.00038	0.000985	CcSEcCtD
Ropinirole—Skin disorder—Ezetimibe—atherosclerosis	0.00038	0.000985	CcSEcCtD
Ropinirole—Angioedema—Pravastatin—atherosclerosis	0.000378	0.000979	CcSEcCtD
Ropinirole—Vertigo—Niacin—atherosclerosis	0.000377	0.000977	CcSEcCtD
Ropinirole—Syncope—Niacin—atherosclerosis	0.000377	0.000975	CcSEcCtD
Ropinirole—Confusional state—Simvastatin—atherosclerosis	0.000376	0.000975	CcSEcCtD
Ropinirole—Leukopenia—Niacin—atherosclerosis	0.000376	0.000974	CcSEcCtD
Ropinirole—Urticaria—Rosuvastatin—atherosclerosis	0.000374	0.000969	CcSEcCtD
Ropinirole—Oedema—Simvastatin—atherosclerosis	0.000373	0.000967	CcSEcCtD
Ropinirole—Malaise—Pravastatin—atherosclerosis	0.000373	0.000966	CcSEcCtD
Ropinirole—Abdominal pain—Rosuvastatin—atherosclerosis	0.000372	0.000964	CcSEcCtD
Ropinirole—Vertigo—Pravastatin—atherosclerosis	0.000371	0.000962	CcSEcCtD
Ropinirole—Palpitations—Niacin—atherosclerosis	0.000371	0.000961	CcSEcCtD
Ropinirole—Infection—Simvastatin—atherosclerosis	0.000371	0.00096	CcSEcCtD
Ropinirole—Leukopenia—Pravastatin—atherosclerosis	0.00037	0.000959	CcSEcCtD
Ropinirole—Loss of consciousness—Niacin—atherosclerosis	0.000369	0.000956	CcSEcCtD
Ropinirole—Cough—Niacin—atherosclerosis	0.000366	0.000949	CcSEcCtD
Ropinirole—Thrombocytopenia—Simvastatin—atherosclerosis	0.000365	0.000947	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000364	0.000942	CcSEcCtD
Ropinirole—Insomnia—Lovastatin—atherosclerosis	0.000361	0.000935	CcSEcCtD
Ropinirole—Cough—Pravastatin—atherosclerosis	0.000361	0.000934	CcSEcCtD
Ropinirole—Paraesthesia—Lovastatin—atherosclerosis	0.000358	0.000928	CcSEcCtD
Ropinirole—Arthralgia—Niacin—atherosclerosis	0.000358	0.000926	CcSEcCtD
Ropinirole—Myalgia—Niacin—atherosclerosis	0.000358	0.000926	CcSEcCtD
Ropinirole—Hypertension—Pravastatin—atherosclerosis	0.000357	0.000925	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000357	0.000924	CcSEcCtD
Ropinirole—CYP1A2—liver—atherosclerosis	0.000356	0.0103	CbGeAlD
Ropinirole—Anorexia—Simvastatin—atherosclerosis	0.000356	0.000921	CcSEcCtD
Ropinirole—Dyspnoea—Lovastatin—atherosclerosis	0.000356	0.000921	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000355	0.00092	CcSEcCtD
Ropinirole—Insomnia—Ezetimibe—atherosclerosis	0.000354	0.000917	CcSEcCtD
Ropinirole—Myalgia—Pravastatin—atherosclerosis	0.000352	0.000912	CcSEcCtD
Ropinirole—Chest pain—Pravastatin—atherosclerosis	0.000352	0.000912	CcSEcCtD
Ropinirole—Arthralgia—Pravastatin—atherosclerosis	0.000352	0.000912	CcSEcCtD
Ropinirole—Paraesthesia—Ezetimibe—atherosclerosis	0.000351	0.00091	CcSEcCtD
Ropinirole—Dyspepsia—Lovastatin—atherosclerosis	0.000351	0.00091	CcSEcCtD
Ropinirole—Anxiety—Pravastatin—atherosclerosis	0.000351	0.000909	CcSEcCtD
Ropinirole—Dry mouth—Niacin—atherosclerosis	0.00035	0.000906	CcSEcCtD
Ropinirole—Dyspnoea—Ezetimibe—atherosclerosis	0.000349	0.000904	CcSEcCtD
Ropinirole—Discomfort—Pravastatin—atherosclerosis	0.000348	0.000901	CcSEcCtD
Ropinirole—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000347	0.000899	CcSEcCtD
Ropinirole—Decreased appetite—Lovastatin—atherosclerosis	0.000347	0.000898	CcSEcCtD
Ropinirole—Dyspepsia—Ezetimibe—atherosclerosis	0.000345	0.000892	CcSEcCtD
Ropinirole—Fatigue—Lovastatin—atherosclerosis	0.000344	0.000891	CcSEcCtD
Ropinirole—Oedema—Niacin—atherosclerosis	0.000343	0.000888	CcSEcCtD
Ropinirole—Pain—Lovastatin—atherosclerosis	0.000341	0.000884	CcSEcCtD
Ropinirole—Constipation—Lovastatin—atherosclerosis	0.000341	0.000884	CcSEcCtD
Ropinirole—Confusional state—Pravastatin—atherosclerosis	0.00034	0.000881	CcSEcCtD
Ropinirole—Decreased appetite—Ezetimibe—atherosclerosis	0.00034	0.000881	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00034	0.000881	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000338	0.000875	CcSEcCtD
Ropinirole—Asthenia—Rosuvastatin—atherosclerosis	0.000338	0.000875	CcSEcCtD
Ropinirole—Insomnia—Simvastatin—atherosclerosis	0.000338	0.000874	CcSEcCtD
Ropinirole—Oedema—Pravastatin—atherosclerosis	0.000337	0.000874	CcSEcCtD
Ropinirole—Fatigue—Ezetimibe—atherosclerosis	0.000337	0.000874	CcSEcCtD
Ropinirole—Shock—Niacin—atherosclerosis	0.000337	0.000873	CcSEcCtD
Ropinirole—Infection—Pravastatin—atherosclerosis	0.000335	0.000868	CcSEcCtD
Ropinirole—Paraesthesia—Simvastatin—atherosclerosis	0.000335	0.000868	CcSEcCtD
Ropinirole—Pain—Ezetimibe—atherosclerosis	0.000335	0.000867	CcSEcCtD
Ropinirole—Constipation—Ezetimibe—atherosclerosis	0.000335	0.000867	CcSEcCtD
Ropinirole—Tachycardia—Niacin—atherosclerosis	0.000334	0.000866	CcSEcCtD
Ropinirole—Pruritus—Rosuvastatin—atherosclerosis	0.000333	0.000863	CcSEcCtD
Ropinirole—Skin disorder—Niacin—atherosclerosis	0.000333	0.000862	CcSEcCtD
Ropinirole—Dyspnoea—Simvastatin—atherosclerosis	0.000333	0.000862	CcSEcCtD
Ropinirole—Hyperhidrosis—Niacin—atherosclerosis	0.000331	0.000858	CcSEcCtD
Ropinirole—Thrombocytopenia—Pravastatin—atherosclerosis	0.00033	0.000856	CcSEcCtD
Ropinirole—Feeling abnormal—Lovastatin—atherosclerosis	0.000329	0.000852	CcSEcCtD
Ropinirole—Dyspepsia—Simvastatin—atherosclerosis	0.000329	0.000851	CcSEcCtD
Ropinirole—Anorexia—Niacin—atherosclerosis	0.000327	0.000846	CcSEcCtD
Ropinirole—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000326	0.000845	CcSEcCtD
Ropinirole—Hyperhidrosis—Pravastatin—atherosclerosis	0.000326	0.000845	CcSEcCtD
Ropinirole—Decreased appetite—Simvastatin—atherosclerosis	0.000324	0.00084	CcSEcCtD
Ropinirole—Feeling abnormal—Ezetimibe—atherosclerosis	0.000323	0.000835	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000322	0.000835	CcSEcCtD
Ropinirole—Diarrhoea—Rosuvastatin—atherosclerosis	0.000322	0.000834	CcSEcCtD
Ropinirole—Fatigue—Simvastatin—atherosclerosis	0.000322	0.000833	CcSEcCtD
Ropinirole—Anorexia—Pravastatin—atherosclerosis	0.000322	0.000833	CcSEcCtD
Ropinirole—Hypotension—Niacin—atherosclerosis	0.00032	0.000829	CcSEcCtD
Ropinirole—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00032	0.000829	CcSEcCtD
Ropinirole—Pain—Simvastatin—atherosclerosis	0.000319	0.000827	CcSEcCtD
Ropinirole—Constipation—Simvastatin—atherosclerosis	0.000319	0.000827	CcSEcCtD
Ropinirole—Urticaria—Lovastatin—atherosclerosis	0.000317	0.000821	CcSEcCtD
Ropinirole—Abdominal pain—Lovastatin—atherosclerosis	0.000315	0.000817	CcSEcCtD
Ropinirole—Body temperature increased—Lovastatin—atherosclerosis	0.000315	0.000817	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000312	0.000809	CcSEcCtD
Ropinirole—Dizziness—Rosuvastatin—atherosclerosis	0.000311	0.000806	CcSEcCtD
Ropinirole—Urticaria—Ezetimibe—atherosclerosis	0.000311	0.000805	CcSEcCtD
Ropinirole—Insomnia—Niacin—atherosclerosis	0.00031	0.000803	CcSEcCtD
Ropinirole—Body temperature increased—Ezetimibe—atherosclerosis	0.000309	0.000801	CcSEcCtD
Ropinirole—Abdominal pain—Ezetimibe—atherosclerosis	0.000309	0.000801	CcSEcCtD
Ropinirole—Paraesthesia—Niacin—atherosclerosis	0.000308	0.000797	CcSEcCtD
Ropinirole—Feeling abnormal—Simvastatin—atherosclerosis	0.000308	0.000797	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000307	0.000796	CcSEcCtD
Ropinirole—Dyspnoea—Niacin—atherosclerosis	0.000306	0.000791	CcSEcCtD
Ropinirole—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000305	0.000791	CcSEcCtD
Ropinirole—Insomnia—Pravastatin—atherosclerosis	0.000305	0.00079	CcSEcCtD
Ropinirole—Somnolence—Niacin—atherosclerosis	0.000305	0.000789	CcSEcCtD
Ropinirole—Paraesthesia—Pravastatin—atherosclerosis	0.000303	0.000785	CcSEcCtD
Ropinirole—Dyspepsia—Niacin—atherosclerosis	0.000302	0.000781	CcSEcCtD
Ropinirole—Dyspnoea—Pravastatin—atherosclerosis	0.000301	0.000779	CcSEcCtD
Ropinirole—Decreased appetite—Niacin—atherosclerosis	0.000298	0.000772	CcSEcCtD
Ropinirole—Dyspepsia—Pravastatin—atherosclerosis	0.000297	0.000769	CcSEcCtD
Ropinirole—Rash—Rosuvastatin—atherosclerosis	0.000297	0.000769	CcSEcCtD
Ropinirole—Dermatitis—Rosuvastatin—atherosclerosis	0.000297	0.000768	CcSEcCtD
Ropinirole—Urticaria—Simvastatin—atherosclerosis	0.000297	0.000768	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Niacin—atherosclerosis	0.000296	0.000766	CcSEcCtD
Ropinirole—Abdominal pain—Simvastatin—atherosclerosis	0.000295	0.000764	CcSEcCtD
Ropinirole—Body temperature increased—Simvastatin—atherosclerosis	0.000295	0.000764	CcSEcCtD
Ropinirole—Headache—Rosuvastatin—atherosclerosis	0.000295	0.000764	CcSEcCtD
Ropinirole—Hypersensitivity—Lovastatin—atherosclerosis	0.000294	0.000761	CcSEcCtD
Ropinirole—Decreased appetite—Pravastatin—atherosclerosis	0.000293	0.00076	CcSEcCtD
Ropinirole—Pain—Niacin—atherosclerosis	0.000293	0.000759	CcSEcCtD
Ropinirole—Fatigue—Pravastatin—atherosclerosis	0.000291	0.000754	CcSEcCtD
Ropinirole—Pain—Pravastatin—atherosclerosis	0.000289	0.000747	CcSEcCtD
Ropinirole—Constipation—Pravastatin—atherosclerosis	0.000289	0.000747	CcSEcCtD
Ropinirole—Hypersensitivity—Ezetimibe—atherosclerosis	0.000288	0.000747	CcSEcCtD
Ropinirole—Asthenia—Lovastatin—atherosclerosis	0.000286	0.000742	CcSEcCtD
Ropinirole—Pruritus—Lovastatin—atherosclerosis	0.000282	0.000731	CcSEcCtD
Ropinirole—Asthenia—Ezetimibe—atherosclerosis	0.000281	0.000727	CcSEcCtD
Ropinirole—Gastrointestinal pain—Niacin—atherosclerosis	0.00028	0.000726	CcSEcCtD
Ropinirole—Nausea—Rosuvastatin—atherosclerosis	0.00028	0.000724	CcSEcCtD
Ropinirole—HTR2A—liver—atherosclerosis	0.000279	0.00803	CbGeAlD
Ropinirole—Feeling abnormal—Pravastatin—atherosclerosis	0.000278	0.00072	CcSEcCtD
Ropinirole—Pruritus—Ezetimibe—atherosclerosis	0.000277	0.000717	CcSEcCtD
Ropinirole—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000276	0.000715	CcSEcCtD
Ropinirole—Hypersensitivity—Simvastatin—atherosclerosis	0.000275	0.000712	CcSEcCtD
Ropinirole—Diarrhoea—Lovastatin—atherosclerosis	0.000273	0.000707	CcSEcCtD
Ropinirole—Urticaria—Niacin—atherosclerosis	0.000272	0.000705	CcSEcCtD
Ropinirole—Abdominal pain—Niacin—atherosclerosis	0.000271	0.000702	CcSEcCtD
Ropinirole—Body temperature increased—Niacin—atherosclerosis	0.000271	0.000702	CcSEcCtD
Ropinirole—Urticaria—Pravastatin—atherosclerosis	0.000268	0.000694	CcSEcCtD
Ropinirole—Asthenia—Simvastatin—atherosclerosis	0.000268	0.000694	CcSEcCtD
Ropinirole—Diarrhoea—Ezetimibe—atherosclerosis	0.000268	0.000694	CcSEcCtD
Ropinirole—Abdominal pain—Pravastatin—atherosclerosis	0.000267	0.000691	CcSEcCtD
Ropinirole—Body temperature increased—Pravastatin—atherosclerosis	0.000267	0.000691	CcSEcCtD
Ropinirole—Pruritus—Simvastatin—atherosclerosis	0.000264	0.000684	CcSEcCtD
Ropinirole—Dizziness—Lovastatin—atherosclerosis	0.000264	0.000683	CcSEcCtD
Ropinirole—Dizziness—Ezetimibe—atherosclerosis	0.000259	0.00067	CcSEcCtD
Ropinirole—CYP3A4—liver—atherosclerosis	0.000258	0.00743	CbGeAlD
Ropinirole—Diarrhoea—Simvastatin—atherosclerosis	0.000255	0.000661	CcSEcCtD
Ropinirole—CYP2D6—liver—atherosclerosis	0.000254	0.00731	CbGeAlD
Ropinirole—Vomiting—Lovastatin—atherosclerosis	0.000254	0.000657	CcSEcCtD
Ropinirole—Hypersensitivity—Niacin—atherosclerosis	0.000253	0.000654	CcSEcCtD
Ropinirole—Rash—Lovastatin—atherosclerosis	0.000252	0.000652	CcSEcCtD
Ropinirole—Dermatitis—Lovastatin—atherosclerosis	0.000251	0.000651	CcSEcCtD
Ropinirole—Headache—Lovastatin—atherosclerosis	0.00025	0.000647	CcSEcCtD
Ropinirole—Vomiting—Ezetimibe—atherosclerosis	0.000249	0.000645	CcSEcCtD
Ropinirole—Hypersensitivity—Pravastatin—atherosclerosis	0.000249	0.000644	CcSEcCtD
Ropinirole—Dizziness—Simvastatin—atherosclerosis	0.000247	0.000639	CcSEcCtD
Ropinirole—Rash—Ezetimibe—atherosclerosis	0.000247	0.000639	CcSEcCtD
Ropinirole—Dermatitis—Ezetimibe—atherosclerosis	0.000247	0.000639	CcSEcCtD
Ropinirole—Asthenia—Niacin—atherosclerosis	0.000246	0.000637	CcSEcCtD
Ropinirole—Headache—Ezetimibe—atherosclerosis	0.000245	0.000635	CcSEcCtD
Ropinirole—Pruritus—Niacin—atherosclerosis	0.000242	0.000628	CcSEcCtD
Ropinirole—Asthenia—Pravastatin—atherosclerosis	0.000242	0.000627	CcSEcCtD
Ropinirole—Pruritus—Pravastatin—atherosclerosis	0.000239	0.000618	CcSEcCtD
Ropinirole—Vomiting—Simvastatin—atherosclerosis	0.000237	0.000615	CcSEcCtD
Ropinirole—Nausea—Lovastatin—atherosclerosis	0.000237	0.000614	CcSEcCtD
Ropinirole—Rash—Simvastatin—atherosclerosis	0.000235	0.00061	CcSEcCtD
Ropinirole—Dermatitis—Simvastatin—atherosclerosis	0.000235	0.000609	CcSEcCtD
Ropinirole—Diarrhoea—Niacin—atherosclerosis	0.000234	0.000607	CcSEcCtD
Ropinirole—Headache—Simvastatin—atherosclerosis	0.000234	0.000606	CcSEcCtD
Ropinirole—Nausea—Ezetimibe—atherosclerosis	0.000232	0.000602	CcSEcCtD
Ropinirole—Diarrhoea—Pravastatin—atherosclerosis	0.000231	0.000598	CcSEcCtD
Ropinirole—Dizziness—Niacin—atherosclerosis	0.000227	0.000587	CcSEcCtD
Ropinirole—Dizziness—Pravastatin—atherosclerosis	0.000223	0.000578	CcSEcCtD
Ropinirole—Nausea—Simvastatin—atherosclerosis	0.000222	0.000574	CcSEcCtD
Ropinirole—Vomiting—Niacin—atherosclerosis	0.000218	0.000564	CcSEcCtD
Ropinirole—Rash—Niacin—atherosclerosis	0.000216	0.00056	CcSEcCtD
Ropinirole—Dermatitis—Niacin—atherosclerosis	0.000216	0.000559	CcSEcCtD
Ropinirole—Headache—Niacin—atherosclerosis	0.000215	0.000556	CcSEcCtD
Ropinirole—Vomiting—Pravastatin—atherosclerosis	0.000215	0.000556	CcSEcCtD
Ropinirole—Rash—Pravastatin—atherosclerosis	0.000213	0.000551	CcSEcCtD
Ropinirole—Dermatitis—Pravastatin—atherosclerosis	0.000213	0.000551	CcSEcCtD
Ropinirole—Headache—Pravastatin—atherosclerosis	0.000211	0.000548	CcSEcCtD
Ropinirole—Nausea—Niacin—atherosclerosis	0.000204	0.000527	CcSEcCtD
Ropinirole—Nausea—Pravastatin—atherosclerosis	0.0002	0.000519	CcSEcCtD
Ropinirole—HTR2A—Signaling Pathways—PIK3CG—atherosclerosis	1.03e-05	4.49e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—IL6—atherosclerosis	1.03e-05	4.49e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CAV1—atherosclerosis	1.03e-05	4.49e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—APOC3—atherosclerosis	1.03e-05	4.48e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—APOA1—atherosclerosis	1.03e-05	4.48e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—MMP9—atherosclerosis	1.03e-05	4.48e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—NOS3—atherosclerosis	1.03e-05	4.47e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—LDLR—atherosclerosis	1.03e-05	4.46e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—CXCL8—atherosclerosis	1.02e-05	4.45e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—NFKB1—atherosclerosis	1.02e-05	4.43e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—MAPK8—atherosclerosis	1.02e-05	4.42e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling by GPCR—AKT1—atherosclerosis	1.01e-05	4.41e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—APOB—atherosclerosis	1.01e-05	4.41e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—CXCL8—atherosclerosis	1.01e-05	4.4e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—SERPINE1—atherosclerosis	1.01e-05	4.38e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—MAPK3—atherosclerosis	1.01e-05	4.37e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CETP—atherosclerosis	1e-05	4.35e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—MAPK8—atherosclerosis	1e-05	4.35e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling by GPCR—AKT1—atherosclerosis	9.99e-06	4.34e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—ESR1—atherosclerosis	9.95e-06	4.33e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—INS—atherosclerosis	9.95e-06	4.32e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—NOS3—atherosclerosis	9.93e-06	4.32e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—MAPK3—atherosclerosis	9.9e-06	4.3e-05	CbGpPWpGaD
Ropinirole—DRD1—GPCR downstream signaling—AKT1—atherosclerosis	9.9e-06	4.3e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—NOS3—atherosclerosis	9.88e-06	4.3e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—GSTM1—atherosclerosis	9.87e-06	4.29e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—F2—atherosclerosis	9.83e-06	4.27e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—MMP9—atherosclerosis	9.83e-06	4.27e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—INS—atherosclerosis	9.79e-06	4.25e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CCL2—atherosclerosis	9.79e-06	4.25e-05	CbGpPWpGaD
Ropinirole—DRD3—GPCR downstream signaling—AKT1—atherosclerosis	9.77e-06	4.25e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—ALB—atherosclerosis	9.76e-06	4.24e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—IL6—atherosclerosis	9.74e-06	4.24e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—NFKB1—atherosclerosis	9.72e-06	4.23e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—LPL—atherosclerosis	9.69e-06	4.21e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CCL2—atherosclerosis	9.63e-06	4.19e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—IGF1—atherosclerosis	9.62e-06	4.18e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—IL6—atherosclerosis	9.61e-06	4.18e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—NOS3—atherosclerosis	9.61e-06	4.18e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—VEGFA—atherosclerosis	9.59e-06	4.17e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—SCARB1—atherosclerosis	9.59e-06	4.17e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—MAPK8—atherosclerosis	9.56e-06	4.15e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—AKT1—atherosclerosis	9.53e-06	4.14e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—STAT3—atherosclerosis	9.5e-06	4.13e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—IGF1—atherosclerosis	9.47e-06	4.11e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—GPX1—atherosclerosis	9.45e-06	4.11e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PIK3CG—atherosclerosis	9.41e-06	4.09e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—VEGFA—atherosclerosis	9.39e-06	4.08e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—NOS3—atherosclerosis	9.34e-06	4.06e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—STAT3—atherosclerosis	9.3e-06	4.04e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—MMP9—atherosclerosis	9.27e-06	4.03e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—VEGFA—atherosclerosis	9.24e-06	4.02e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—CD36—atherosclerosis	9.21e-06	4e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—NFKB1—atherosclerosis	9.17e-06	3.99e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—STAT3—atherosclerosis	9.15e-06	3.98e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—MMP9—atherosclerosis	9.14e-06	3.98e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—SERPINE1—atherosclerosis	9.14e-06	3.97e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CXCL8—atherosclerosis	9.13e-06	3.97e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—MAPK3—atherosclerosis	9.08e-06	3.95e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—HMGCR—atherosclerosis	9.06e-06	3.94e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—NFKB1—atherosclerosis	9.05e-06	3.93e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—MAPK8—atherosclerosis	9.01e-06	3.92e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—MAPK3—atherosclerosis	9.01e-06	3.92e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—AKT1—atherosclerosis	8.99e-06	3.91e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—SERPINE1—atherosclerosis	8.99e-06	3.91e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—HMOX1—atherosclerosis	8.97e-06	3.9e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—INS—atherosclerosis	8.9e-06	3.87e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—MAPK8—atherosclerosis	8.89e-06	3.87e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—MAPK3—atherosclerosis	8.89e-06	3.86e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—AKT1—atherosclerosis	8.87e-06	3.86e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—VEGFA—atherosclerosis	8.83e-06	3.84e-05	CbGpPWpGaD
Ropinirole—ADRA2B—GPCR downstream signaling—AKT1—atherosclerosis	8.82e-06	3.83e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CXCL8—atherosclerosis	8.81e-06	3.83e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—TGFB1—atherosclerosis	8.81e-06	3.83e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CXCL8—atherosclerosis	8.77e-06	3.81e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CCL2—atherosclerosis	8.76e-06	3.81e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—MAPK3—atherosclerosis	8.75e-06	3.8e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—STAT3—atherosclerosis	8.74e-06	3.8e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—MTHFR—atherosclerosis	8.72e-06	3.79e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—NOS3—atherosclerosis	8.72e-06	3.79e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—IL6—atherosclerosis	8.68e-06	3.77e-05	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—IL6—atherosclerosis	8.66e-06	3.77e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—TGFB1—atherosclerosis	8.62e-06	3.75e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—IGF1—atherosclerosis	8.61e-06	3.74e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—APOB—atherosclerosis	8.6e-06	3.74e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—NOS3—atherosclerosis	8.58e-06	3.73e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PPARA—atherosclerosis	8.56e-06	3.72e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—PTGS2—atherosclerosis	8.54e-06	3.71e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CXCL8—atherosclerosis	8.53e-06	3.71e-05	CbGpPWpGaD
Ropinirole—HTR1A—GPCR downstream signaling—AKT1—atherosclerosis	8.51e-06	3.7e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—TGFB1—atherosclerosis	8.49e-06	3.69e-05	CbGpPWpGaD
Ropinirole—HTR2C—GPCR downstream signaling—AKT1—atherosclerosis	8.47e-06	3.68e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—IL6—atherosclerosis	8.38e-06	3.64e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—GSTM1—atherosclerosis	8.36e-06	3.64e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—MAPK3—atherosclerosis	8.35e-06	3.63e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—IL6—atherosclerosis	8.34e-06	3.62e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—VEGFA—atherosclerosis	8.32e-06	3.62e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—AGT—atherosclerosis	8.29e-06	3.6e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MMP9—atherosclerosis	8.26e-06	3.59e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—STAT3—atherosclerosis	8.24e-06	3.58e-05	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR downstream signaling—AKT1—atherosclerosis	8.24e-06	3.58e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—VEGFA—atherosclerosis	8.21e-06	3.57e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—LPL—atherosclerosis	8.21e-06	3.57e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—SERPINE1—atherosclerosis	8.18e-06	3.55e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—NFKB1—atherosclerosis	8.17e-06	3.55e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—STAT3—atherosclerosis	8.13e-06	3.53e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—APOE—atherosclerosis	8.12e-06	3.53e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—IL6—atherosclerosis	8.11e-06	3.52e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—TGFB1—atherosclerosis	8.1e-06	3.52e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ABCA1—atherosclerosis	8.07e-06	3.51e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—CAV1—atherosclerosis	8.05e-06	3.5e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MAPK8—atherosclerosis	8.03e-06	3.49e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—APOA1—atherosclerosis	8.03e-06	3.49e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—GPX1—atherosclerosis	8.01e-06	3.48e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—AKT1—atherosclerosis	8.01e-06	3.48e-05	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—AKT1—atherosclerosis	7.99e-06	3.47e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MMP9—atherosclerosis	7.97e-06	3.46e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MMP9—atherosclerosis	7.93e-06	3.45e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—NFKB1—atherosclerosis	7.89e-06	3.43e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—MAPK3—atherosclerosis	7.87e-06	3.42e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—NFKB1—atherosclerosis	7.84e-06	3.41e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—NOS3—atherosclerosis	7.81e-06	3.39e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—CD36—atherosclerosis	7.8e-06	3.39e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—MAPK3—atherosclerosis	7.77e-06	3.38e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MAPK8—atherosclerosis	7.75e-06	3.37e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CXCL8—atherosclerosis	7.74e-06	3.36e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—AKT1—atherosclerosis	7.73e-06	3.36e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MMP9—atherosclerosis	7.71e-06	3.35e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MAPK8—atherosclerosis	7.71e-06	3.35e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—AKT1—atherosclerosis	7.69e-06	3.34e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—TGFB1—atherosclerosis	7.64e-06	3.32e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—NFKB1—atherosclerosis	7.63e-06	3.32e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CXCL8—atherosclerosis	7.61e-06	3.31e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—TGFB1—atherosclerosis	7.54e-06	3.28e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MAPK8—atherosclerosis	7.5e-06	3.26e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—AKT1—atherosclerosis	7.48e-06	3.25e-05	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—AKT1—atherosclerosis	7.47e-06	3.25e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—VEGFA—atherosclerosis	7.41e-06	3.22e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—MTHFR—atherosclerosis	7.39e-06	3.21e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—IL6—atherosclerosis	7.36e-06	3.2e-05	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—AKT1—atherosclerosis	7.35e-06	3.2e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—STAT3—atherosclerosis	7.34e-06	3.19e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PIK3CG—atherosclerosis	7.33e-06	3.19e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PPARA—atherosclerosis	7.25e-06	3.15e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—IL6—atherosclerosis	7.24e-06	3.15e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—VEGFA—atherosclerosis	7.16e-06	3.11e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—VEGFA—atherosclerosis	7.12e-06	3.09e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—STAT3—atherosclerosis	7.09e-06	3.08e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PPARG—atherosclerosis	7.07e-06	3.08e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—STAT3—atherosclerosis	7.05e-06	3.06e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—AGT—atherosclerosis	7.02e-06	3.05e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MAPK3—atherosclerosis	7.01e-06	3.05e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MMP9—atherosclerosis	7e-06	3.04e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—INS—atherosclerosis	6.94e-06	3.02e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—HMOX1—atherosclerosis	6.93e-06	3.01e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CXCL8—atherosclerosis	6.93e-06	3.01e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—VEGFA—atherosclerosis	6.93e-06	3.01e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—NFKB1—atherosclerosis	6.92e-06	3.01e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MMP9—atherosclerosis	6.89e-06	2.99e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—APOE—atherosclerosis	6.88e-06	2.99e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—STAT3—atherosclerosis	6.86e-06	2.98e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—CAV1—atherosclerosis	6.82e-06	2.96e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—NFKB1—atherosclerosis	6.81e-06	2.96e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MAPK8—atherosclerosis	6.81e-06	2.96e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—TGFB1—atherosclerosis	6.8e-06	2.96e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—APOA1—atherosclerosis	6.8e-06	2.96e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—AKT1—atherosclerosis	6.79e-06	2.95e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MAPK3—atherosclerosis	6.77e-06	2.94e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MAPK3—atherosclerosis	6.74e-06	2.93e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MAPK8—atherosclerosis	6.7e-06	2.91e-05	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—AKT1—atherosclerosis	6.69e-06	2.91e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—AKT1—atherosclerosis	6.68e-06	2.9e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—IL6—atherosclerosis	6.64e-06	2.88e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—APOB—atherosclerosis	6.63e-06	2.88e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—IL6—atherosclerosis	6.59e-06	2.86e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—TGFB1—atherosclerosis	6.57e-06	2.86e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MAPK3—atherosclerosis	6.55e-06	2.85e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—TGFB1—atherosclerosis	6.53e-06	2.84e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—IL6—atherosclerosis	6.5e-06	2.82e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GSTM1—atherosclerosis	6.45e-06	2.81e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—IL6—atherosclerosis	6.39e-06	2.78e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—ALB—atherosclerosis	6.36e-06	2.77e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—TGFB1—atherosclerosis	6.36e-06	2.76e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—LPL—atherosclerosis	6.33e-06	2.75e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—VEGFA—atherosclerosis	6.28e-06	2.73e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MMP9—atherosclerosis	6.26e-06	2.72e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—STAT3—atherosclerosis	6.22e-06	2.7e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PIK3CG—atherosclerosis	6.21e-06	2.7e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—NFKB1—atherosclerosis	6.2e-06	2.69e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—VEGFA—atherosclerosis	6.18e-06	2.69e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GPX1—atherosclerosis	6.18e-06	2.69e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—AKT1—atherosclerosis	6.12e-06	2.66e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—STAT3—atherosclerosis	6.12e-06	2.66e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—IL6—atherosclerosis	6.1e-06	2.65e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MAPK8—atherosclerosis	6.09e-06	2.65e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—NOS3—atherosclerosis	6.08e-06	2.64e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—AKT1—atherosclerosis	6.08e-06	2.64e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CD36—atherosclerosis	6.02e-06	2.62e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—AKT1—atherosclerosis	5.99e-06	2.61e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PPARG—atherosclerosis	5.99e-06	2.61e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MAPK3—atherosclerosis	5.94e-06	2.58e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—AKT1—atherosclerosis	5.9e-06	2.56e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—INS—atherosclerosis	5.88e-06	2.56e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MAPK3—atherosclerosis	5.85e-06	2.54e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—TGFB1—atherosclerosis	5.77e-06	2.51e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—IL6—atherosclerosis	5.76e-06	2.5e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—MTHFR—atherosclerosis	5.7e-06	2.48e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—IL6—atherosclerosis	5.68e-06	2.47e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—TGFB1—atherosclerosis	5.67e-06	2.47e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—AKT1—atherosclerosis	5.63e-06	2.45e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—VEGFA—atherosclerosis	5.62e-06	2.45e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PPARA—atherosclerosis	5.6e-06	2.43e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—STAT3—atherosclerosis	5.57e-06	2.42e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PTGS2—atherosclerosis	5.56e-06	2.42e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—AGT—atherosclerosis	5.42e-06	2.36e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—ALB—atherosclerosis	5.39e-06	2.34e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MAPK3—atherosclerosis	5.32e-06	2.31e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—AKT1—atherosclerosis	5.31e-06	2.31e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—APOE—atherosclerosis	5.31e-06	2.31e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—AKT1—atherosclerosis	5.28e-06	2.3e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CAV1—atherosclerosis	5.26e-06	2.29e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—APOA1—atherosclerosis	5.25e-06	2.28e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—AKT1—atherosclerosis	5.24e-06	2.28e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—TGFB1—atherosclerosis	5.16e-06	2.24e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—NOS3—atherosclerosis	5.15e-06	2.24e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—IL6—atherosclerosis	5.13e-06	2.23e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—IL6—atherosclerosis	4.95e-06	2.15e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—IL6—atherosclerosis	4.92e-06	2.14e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PIK3CG—atherosclerosis	4.79e-06	2.08e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—IL6—atherosclerosis	4.79e-06	2.08e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—AKT1—atherosclerosis	4.73e-06	2.06e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PTGS2—atherosclerosis	4.71e-06	2.05e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PPARG—atherosclerosis	4.63e-06	2.01e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—AKT1—atherosclerosis	4.57e-06	1.98e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—AKT1—atherosclerosis	4.54e-06	1.97e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—INS—atherosclerosis	4.54e-06	1.97e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—AKT1—atherosclerosis	4.42e-06	1.92e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—IL6—atherosclerosis	4.35e-06	1.89e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—AKT1—atherosclerosis	4.29e-06	1.87e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—IL6—atherosclerosis	4.28e-06	1.86e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ALB—atherosclerosis	4.16e-06	1.81e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—AKT1—atherosclerosis	4.01e-06	1.74e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—NOS3—atherosclerosis	3.98e-06	1.73e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—AKT1—atherosclerosis	3.94e-06	1.71e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—IL6—atherosclerosis	3.89e-06	1.69e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PTGS2—atherosclerosis	3.64e-06	1.58e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—AKT1—atherosclerosis	3.59e-06	1.56e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—AKT1—atherosclerosis	2.8e-06	1.22e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—AKT1—atherosclerosis	2.37e-06	1.03e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—AKT1—atherosclerosis	1.83e-06	7.95e-06	CbGpPWpGaD
